Pharmacologic therapeutics in sarcopenia with chronic kidney disease

• Κύριος συγγραφέας: Ran-hui Cha (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: The Korean Society of Nephrology, 2024-03-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Inflammation, metabolic acidosis, renin-angiotensin system activation, insulin resistance, and impaired perfusion to skeletal muscles, among others, are possible causes of uremic sarcopenia. These conditions induce the activation of the nuclear factor-kappa B and mitogen-activated protein kinase pat...